Month: September 2020

TORONTO, Sept. 16, 2020 (GLOBE NEWSWIRE) — VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce the deployment of newly-acquired Intouch with Health’s digital patient flow solution at newly-built Clatterbridge Cancer Centre – Liverpool (“CCC-L” or “Clatterbridge”).The new Clatterbridge Cancer Centre – Liverpool (CCC-L) is a major new hospital that will transform cancer care in one of the worst-affected areas of the UK, and is part of The Clatterbridge Cancer Centre NHS Foundation Trust. Clatterbridge has deployed VitalHub’s newly acquired Intouch with Health’s digital patient flow solution, to help improve the patient experience and drive efficiency across its cancer clinics.Clatterbridge, an 11-storey hospital, is part of a £162m investment in transforming cancer services across Cheshire and Merseyside....

 Will Help Companies Manage Change, Drive Finance and Operational Excellence and Accelerate Value CreationJosh Herrenkohl Joins to Lead Real Estate Business Transformation PracticeWASHINGTON, Sept. 16, 2020 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that its Real Estate Solutions industry practice has introduced the Real Estate Business Transformation offering for real estate owners and users, a new service offering to help companies better manage the fast-paced change taking place across the real estate industry. Josh Herrenkohl has joined FTI Consulting as a Senior Managing Director and Real Estate Business Transformation Leader.FTI Consulting’s Real Estate Business Transformation practice helps organizations navigate an evolving business environment characterized by significant and fast-paced disruption....

FREMONT, Calif., Sept. 16, 2020 (GLOBE NEWSWIRE) — Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of semiconductor test and reliability qualification equipment, today announced that it will report financial results for its first quarter of fiscal 2021 ended August 31, 2020 on Thursday, September 24, 2020 following the close of the market. The Company will host a conference call and webcast at 5:00 p.m. Eastern time to discuss the results.About Aehr Test SystemsHeadquartered in Fremont, California, Aehr Test Systems is a worldwide provider of test systems for burning-in and testing logic, optical and memory integrated circuits and has installed over 2,500 systems worldwide. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets are driving additional test requirements, incremental...

VANCOUVER, British Columbia, Sept. 16, 2020 (GLOBE NEWSWIRE) — WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical-stage pharmaceutical company, is pleased to announce that it has received a prepayment of approximately C$705,000 (2,000,000 PLN) and approval for reimbursement of approximately C$175,000 (500,000 PLN) from the Polish National Center for Research and Development (“NCRD”) granted by the European Union, under the Smart Growth Operational Program 2014-2020, for the further development of WPD101, the Company’s drug candidate targeting glioblastoma (“GBM”) which includes Phase I clinical studies.The NCRD is an executive agency of the Minister of Science and Higher Education. It was established as a unit implementing tasks in the field of science, technology, and state innovation policy. The...

CAMBRIDGE, Mass., Sept. 16, 2020 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ: VCEL) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the recently submitted Biologics License Application (BLA) for NexoBrid® (concentrate of proteolytic enzymes enriched in bromelain) for eschar removal (debridement) in adults with deep partial-thickness and/or full-thickness thermal burns. The FDA assigned a Prescription Drug User Fee Act (PDUFA) target date of June 29, 2021. In addition, the FDA communicated that it is not currently planning to hold an advisory committee meeting to discuss the application. “The FDA’s acceptance of the NexoBrid BLA for review represents another important milestone toward our goal of providing a new standard of care for eschar removal in patients with severe burns,” said Nick...

YAVNE, Israel, Sept. 16, 2020 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD) (the “MediWound”), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review its recently submitted Biologics License Application (BLA) for NexoBrid® for eschar removal (debridement) in adults with deep partial-thickness and/or full-thickness thermal burns.  The FDA assigned a Prescription Drug User Fee Act (PDUFA) target date of June 29, 2021.  In addition, the FDA communicated that it is not currently planning to hold an advisory committee meeting to discuss the application.“The FDA’s acceptance of the NexoBrid BLA submission for review is a major milestone for MediWound, and it is gratifying...

BOSTON, Sept. 16, 2020 (GLOBE NEWSWIRE) — Today, the New York Giants and DraftKings (Nasdaq: DKNG) announced an exclusive, multi-year arrangement, making DraftKings the Official Sports Betting, iGaming and Daily Fantasy operator of the team. This multi-faceted arrangement grants DraftKings access to official Giants marks and logos, in addition to a first of its kind virtual SportsLounge open on Giants’ game days, providing attendees with unique and innovative ways to engage on all DraftKings platforms.“The New York Giants have continued to be a fantastic organization to work with over the years, and we are excited to expand our relationship as the Giants’ Official Exclusive Sports Betting, iGaming and Daily Fantasy operator,” said Ezra Kucharz, DraftKings’ Chief Business Officer. “Both organizations remain committed to customer...

CALGARY, Alberta, Sept. 16, 2020 (GLOBE NEWSWIRE) — FLYHT Aerospace Solutions Ltd. (TSX-V: FLY) (OTCQX: FLYLF) (the “Company” or “Flyht”) today announced that the Company has developed and is delivering phase one of the Actionable Intelligence suite of SaaS applications. These developments will enable Flyht to combine its proven history of collecting, analysing and reporting aircraft operational data with IBM Watson Knowledge Catalog and IBM Cloud Pak for Data to enhance efficiency, cost and the goal of on time operations for clients like China Express Airlines, Swoop Airlines and its other global customers.  Flyht currently has more than 2,800 aircraft equipped with the patented AFIRSTM system, and provides data analytics and reporting to more than 80 aircraft operators around the globe. The operation supports airlines 24/7 as...

SHANGHAI and SAN FRANCISCO, Sept. 16, 2020 (GLOBE NEWSWIRE) — Zai Lab Limited (“Zai Lab” or the “Company”) (NASDAQ:ZLAB), an innovative commercial stage biopharmaceutical company, today announced the launch of its Hong Kong public offering (the “Hong Kong Public Offering”), which forms part of the global offering (the “Offering”) of 10,564,050 new ordinary shares (the “Offer Shares” or “Shares”) and listing of its ordinary shares on the Main Board of The Stock Exchange of Hong Kong Limited (the “Hong Kong Stock Exchange”) under the stock code “9688”.The Company’s American depositary shares (“ADSs”), each representing one (1) ordinary share of the Company, will continue to be listed and traded on the Nasdaq Global Market (“Nasdaq”). Investors in the Offering will only be able to purchase ordinary shares and will not be able to take...

Pressmeddelande 2020-09-16ArcAromas styrelse och personal/nyckelpersoner förvärvar teckningsoptionerTeckningstiden i ArcAroma AB:s (ArcAroma) emission av teckningsoptioner inom incitamentsprogrammen ArcAroma TO 1 och ArcAroma TO 2 avslutades den 15 september 2020. Styrelse och personal tecknade totalt 701 000 optioner för priset 0,38 kr per option. Teckningen fördelades på 150 000 optioner till styrelsen och 551 000 optioner till personal och nyckelpersoner. Ytterligare 139 300 optioner har placerats i depå inför planerad rekrytering av nyckelpersoner. Vid bolagsstämman den 17 juni 2020 beslutades om ett optionsprogram riktat till styrelseledamöter, personal och externa nyckelpersoner i bolaget. Optionsvillkoren baseras på en marknadsmässig värdering enligt Black & Scholes-modellen, med utgångspunkt från den volymvägda aktiekursen...